Green Thumb Industries Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Benjamin Kovler
- Full Time Employees
- 4,900
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 325 West Huron Street Chicago IL United States of America 60654
- IPO Date
- Jun 14, 2018
- CIK
- 0001795139
- Website
- gtigrows.com
- Similar Companies
- Business
- Green Thumb Industries Inc. (GTBIF) manufactures, distributes, markets and sells branded cannabis products for medical and adult-use markets in the United States; operates more than 100 retail dispensaries under the RISE brand; and provides direct-to-consumer delivery services. The company offers a portfolio of consumer packaged goods including flower, vapes, concentrates, edibles and health products under brands such as &Shine, Doctor Solomon’s, Good Green, incredibles and The Feel Collection. Green Thumb Industries conducts operations across 14 states with a focus on limited-license markets featuring large populations, such as Illinois, Pennsylvania, New Jersey, Maryland, Florida, Minnesota, New York and Ohio; founded in 2014, it maintains headquarters in Chicago, Illinois. In August 2025, the company sold select brands including RYTHM, Dogwalkers and Beboe to Agrify Corporation (now RYTHM, Inc.) for $50 million via convertible note, while securing a licensing agreement to continue manufacturing and distributing those brands and extending a $45 million loan; it also commenced adult-use sales at seven RISE dispensaries in Minnesota in September 2025 and authorized a $50 million share repurchase program in Q3 2025.
3 Top Marijuana Stocks That Can Make a Profitable Difference
President Trump's Major Marijuana Move: What It Means for Canopy Growth, Green Thumb, and Tilray
Is Green Thumb Stock Oversold? The Case for 100% Upside.
Green Thumb Industries to Report Second Quarter 2026 Financial Results on August 4, 2026
3 Reasons to Buy Green Thumb Industries Stock Hand Over Fist
GTBIF Stock Climbs 17.5% in Three Months: Time to Invest or Cash Out?
Top Cannabis Companies Building Momentum in June 2026
3 Leading Marijuana Stocks Investors Are Watching in June 2026
3 Reasons to Buy Green Thumb Industries Like There's No Tomorrow
The Single Biggest Cannabis Catalyst in Years Is Rapidly Approaching: 2 Marijuana Stocks to Buy Now
Better Buy: Green Thumb Industries vs. Curaleaf Holdings
Curaleaf Prepares for US Exchange Uplisting: Time to Invest?
Green Thumb Industries: Marijuana Meme Stock or Dream Stock?
Is Green Thumb Becoming the "Procter & Gamble of Cannabis"?
3 Marijuana Stocks To Know About Now In 2026
Green Thumb Industries vs. Curaleaf Holdings: Which Cannabis Stock Could Win Biggest From DEA Rescheduling?
Green Thumb Just Made an Unprecedented Move. Here's What It Means for GTBIF Investors.
Green Thumb Industries Will Benefit From Medical Cannabis Rescheduling
Green Thumb Industries Inc. (GTBIF) Q1 2026 Earnings Call Transcript
Green Thumb Industries Reports First Quarter 2026 Results